跳至主要内容
临床试验/NCT02003027
NCT02003027Unknown1 期

Endomyocardial Botulinum Toxin Injection Can Decrease the Number of Episodes of VT Storm: Pilot Study

Meshalkin Research Institute of Pathology of Circulation1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2013年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
发起方
入组人数
15
试验地点
1
主要终点
number of episodes of VT Storm

研究概览

简要总结

The aim of this prospective non-randomized study was to assess the efficacy and safety of endomyocardial botulinum toxin injection in left ventricle for preventing episodes of VT Storm.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 3 or more episodes of ventricular tachycardia within 24 hours

排除标准

  • Failure to provide informed consent.
  • Non-cardiac illness with a life expectancy of less than 3 year
  • Non-cardiac illness imposing substantial operative mortality
  • Current participation in another clinical trial in which a patient is taking an investigational drug or receiving an investigational medical device

研究组 & 干预措施

BT injection

Experimental

干预措施: BT injection (Drug)

结局指标

主要结局

number of episodes of VT Storm

时间窗: 1 year

次要结局

  • serious adverse events(1 year)

研究者

发起方
Meshalkin Research Institute of Pathology of Circulation
申办方类型
Network
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验